First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
47.78
+5.91 (14.12%)
At close: Jul 30, 2026, 4:00 PM EDT
47.53
-0.25 (-0.52%)
After-hours: Jul 30, 2026, 5:16 PM EDT

TRAX Statistics

Total Valuation

TRAX has a market cap or net worth of $1.67 billion. The enterprise value is $1.38 billion.

Market Cap1.67B
Enterprise Value 1.38B

Important Dates

The next estimated earnings date is Thursday, August 13, 2026.

Earnings Date Aug 13, 2026
Ex-Dividend Date n/a

Share Statistics

TRAX has 34.89 million shares outstanding.

Current Share Class 34.89M
Shares Outstanding 34.89M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 1.93%
Owned by Institutions (%) 22.40%
Float 30.22M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 6.47
P/TBV Ratio 6.47
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.74

Current Ratio 8.74
Quick Ratio 8.65
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -70.12%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$1.63M
Employee Count 104
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 23.93
200-Day Moving Average n/a
Relative Strength Index (RSI) 82.41
Average Volume (20 Days) 1,017,933

Short Selling Information

The latest short interest is 4.77 million, so 13.68% of the outstanding shares have been sold short.

Short Interest 4.77M
Short Previous Month 3.91M
Short % of Shares Out 13.68%
Short % of Float 15.79%
Short Ratio (days to cover) 4.92

Income Statement

Revenue n/a
Gross Profit -139.61M
Operating Income -180.54M
Pretax Income -169.38M
Net Income -169.38M
EBITDA -180.00M
EBIT -180.54M
Earnings Per Share (EPS) -$4.85
Full Income Statement

Balance Sheet

The company has $286.46 million in cash and no debt, with a net cash position of $286.46 million or $8.21 per share.

Cash & Cash Equivalents 286.46M
Total Debt n/a
Net Cash 286.46M
Net Cash Per Share $8.21
Equity (Book Value) 257.46M
Book Value Per Share 7.38
Working Capital 256.29M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$130.48 million and capital expenditures -$69,000, giving a free cash flow of -$130.55 million.

Operating Cash Flow -130.48M
Capital Expenditures -69,000
Depreciation & Amortization 538,000
Net Borrowing n/a
Free Cash Flow -130.55M
FCF Per Share -$3.74
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TRAX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -10.17%
FCF Yield -7.84%

Analyst Forecast

The average price target for TRAX is $50.75, which is 6.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target $50.75
Price Target Difference 6.22%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1